Using Quetiapine for Aggression in Specific Contexts

Context-Specific Recommendations

The American Academy of Child and Adolescent Psychiatry suggests that quetiapine has scant literature supporting its use for chemical restraint in children and adolescents, and its use is limited by lack of FDA approval, long period before onset of antipsychotic effect, and lack of injectable form 4, 5, 6
The American College of Clinical Pharmacology recommends that atypical antipsychotics, including quetiapine, should not be used as first-line management for behavioral and psychological symptoms of dementia, as they have only limited positive effects but can cause significant harm in people with dementia 2, 3
The American Psychiatric Association indicates that quetiapine can be used for aggression in specific contexts, particularly in schizoaffective disorder and schizophrenia, but should not be first-line for most aggressive presentations, especially in dementia, and lacks FDA approval for this indication 1, 2

The American Academy of Child and Adolescent Psychiatry recommends that stimulants are first-line when ADHD is present in children and adolescents with conduct disorder and aggression, and divalproex sodium is the preferred adjunctive agent for aggressive outbursts 7, 8

The American College of Clinical Pharmacology advises avoiding rapid addition of multiple medications without assessing response to each change, and avoiding excessive sedation when combining multiple antipsychotics and mood stabilizers 1
The American Geriatrics Society recommends avoiding benzodiazepines as first-line in elderly patients due to risk of paradoxical reactions 1
The National Institute of Mental Health suggests avoiding polypharmacy—trying one medication class thoroughly before switching 7